A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine
Preprint
- 29 April 2022
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
SUMMARY: The authorized mRNA- and adenovirus-based SARS-CoV-2 vaccines are intramuscularly injected and effective in preventing COVID-19, but do not induce efficient mucosal immunity, or prevent viral transmission. We developed a bacteriophage T4-based, multicomponent, needle and adjuvant-free, mucosal vaccine by engineering spike trimers on capsid exterior and nucleocapsid protein in the interior. Intranasal administration of T4-COVID vaccine induced higher virus neutralization antibody titers against multiple variants, balanced Th1/Th2 antibody and cytokine responses, stronger CD4+and CD8+T cell immunity, and higher secretory IgA titers in sera and bronchoalveolar lavage with no effect on the gut microbiota, compared to vaccination of mice intramuscularly. The vaccine is stable at ambient temperature, induces apparent sterilizing immunity, and provides complete protection against original SARS-CoV-2 strain and its Delta variant with minimal lung histopathology. This mucosal vaccine is an excellent candidate for boosting immunity of immunized and/or as a second-generation vaccine for the unimmunized population.Keywords
Other Versions
- Published version: Version mBio, 13, preprints
This publication has 87 references indexed in Scilit:
- Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague VaccinesPLoS Pathogens, 2013
- Bacteriophage adhering to mucus provide a non–host-derived immunityProceedings of the National Academy of Sciences of the United States of America, 2013
- The SILVA ribosomal RNA gene database project: improved data processing and web-based toolsNucleic Acids Research, 2012
- The influence of external factors on bacteriophages—reviewFolia Microbiologica, 2011
- CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccineVaccine, 2011
- Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: Effective recovery of bacterial and archaeal DNA using mechanical cell lysisJournal of Microbiological Methods, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Mucosal Vaccines: Recent Progress in Understanding the Natural BarriersPharmaceutical Research, 2009
- Th17 cells in human diseaseImmunological Reviews, 2008
- The immune geography of IgA induction and functionMucosal Immunology, 2008